- Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
Bioorganic & medicinal chemistry letters (2012-12-26)
Murat Bozdag, Tobias Dreker, Christophe Henry, Paolo Tosco, Maura Vallaro, Roberta Fruttero, Andrea Scozzafava, Fabrizio Carta, Claudiu T Supuran
PMID23265898
RÉSUMÉ
Protein arginin deaminase 4 (PAD4) is a calcium dependent enzyme which catalyses the conversion of peptidyl-arginine into peptidyl-citrulline and is implicated in several diseases such as rheumatoid arthritis (RA) and cancer. Herein we report the discovery of novel small-molecule, non peptidic PAD4 inhibitors incorporating primary/secondary guanidine moieties.
MATÉRIAUX
Référence du produit
Marque
Description du produit
Sigma-Aldrich
Peptidyl Arginine Deiminase from rabbit skeletal muscle, buffered aqueous glycerol solution, ≥200 units/mg protein (Bradford)